Summary
Twenty-six peri- and postmenopausal women with climacteric symptoms were given each day for 1 year a tablet containing 2 mg 17-β-estradiol, 1 mg estriol and 1 mg norethisterone acetate. Blood samples were collected before, after 3 months and after 12 months of treatment and were analysed for their gonadotrophins, estradiol, estrone, testosterone, androstenedione content and for their SHBG binding capacity.
Serum levels of estrone and androstenedione before treatment were found to be higher in the perimenopausal than in the postmenopausal group. An increase of serum estrogens concomitant with a decrease of gonadotrophins was noted. The estrone/estradiol ratios after 3 and 12 months of treatment were 5.3 and 4.7, respectively. A decrease in the serum concentration of testosterone and androstenedione was recorded during treatment. The reduction of gonadotrophins, especially LH, might have been responsible for the reduction in circulating androgens. The reduction of serum levels of androgens during the present long-term replacement therapy could be of metabolic importance.
Similar content being viewed by others
References
Anderson DC (1974) Sex hormone binding globulin. Clin Endocrinol 3: 69–96
Bengtsson C, Lindquist O, Redvall L (1980) Menstrual status and menopausal age of middle-aged Swedish women. Acta Obstet Gynecol Scand 60: 269–275
Burr IM, Grant DB, Sizonenko PC, Kaplan SL, Grumbach MM (1969) Some critical factors in double antibody radioprecipitating sera for measurement of human LH, FSH and HGH. J Clin Endocrinol Metab 29: 948–956
Campbell S, Minardi J, McQueen J, Whitehead MI (1978) The modifying effect of progestogen on the response of the postmenopausal endometrium to exogenous estrogens. Postgrad Med [Suppl 2] 54: 59–64
Cullberg G, Knutsson F, Lindstedt G, Mattsson L-Å, Steffensen K (1982) Ethinylestradiol and a new progestogen (desogestrel) in a low dose combination: Effects on pituitary-gonadal function, serum sex-hormone binding globulin capacity, endometrium and cervical mucus. Acta Obstet Gynecol Scand [Suppl] 111: 29–38
Dada OA, Laumas V, Landgren B-M, Cekan SZ, Diczfalusy E (1978) Effect of graded oral doses of estradiol on circulating hormonal levels. Acta Endocrinol (Copenh) 88: 754–767
Dennis M, Horst HJ, Krieg M, Voigt KD (1977) Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: Comparison with age dependent rise in normal human males. Acta Endocrinol (Copenh) 84: 207–214
Englund DE, Johansson EDB (1978) Plasma levels of estrone, estradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine estrogens (Premarin). Brit J Obstet Gynecol 85: 957–964
Franchimont P, Cessions G, Ayalon D, Musters A, Legros JJ (1970) Suppressive action of norethisterone enanthate and acetate on gonadotrophin (FSH and LH) levels. Obstet Gynecol 36: 93–100
Gambrell RD Jr, Massey FM, Castaneda TA, Ugenas AJ, Ricci CA, Wright JM (1980) Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 55: 732–738
Greenblatt RB, Colle ML, Mahesh VB (1976) Ovarian and adrenal steroid production in the postmenopausal women. Obstet Gynecol 47: 383–387
Helgason S, Damber J-E, Damber M-G, von Schoultz B, Selstam G, Södergård R (1982) A comparative longitudinal study on sex hormone binding globulin capacity during estrogen replacement therapy. Acta Obstet Gynecol Scand 61: 97–100
Ismail AAA, Niswender GD, Midgley AR Jr (1972) Radioimmunoassay of testosterone without chromatography. J Clin Endocrinol Metab 34: 177–184
Lagrelius A, Carlström K, Lunell NO (1981) Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects. Acta Obstet Gynecol Scand 60: 33–38
Longcope C (1974) Steroid production in pre- and postmenopausal women. In: Greenblatt RB, Mahesh VB, McDonough PG (eds) The menopausal syndrome. Medcom Press, New York, pp 6–11
Mattsson L-Å, Cullberg G, Samsioe G (1982) Evaluation of a continuous estrogen-progestogen regimen for climacteric complaints. Maturitas 4: 95–102
Mikhail G, Wu CH, Ferin M, Van de Wiele RL (1970) Radioimmunoassay of plasma estrone and estradiol. Steroids 15: 333–352
Odlind V, Weiner E, Victor A, Johansson EDB (1980) Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Br J Obstet Gynaecol 87: 416–421
Parker LP, Grover PK, Odell ND (1977) An improved radioimmunoassay for 4-androsten-3, 17-dione. Steroids 29: 715–724
Rose DP, Fern M, Liskowski L, Milbrath JR (1977) Effect of treatment with estrogen conjugates on endogenous plasma steroids. Obstet Gynecol 49: 80–82
Ryan KJ, Engel LL (1953) The interconversion of estrone and estradiol by human tissue slices. Endocrinology 52: 287–291
Sexton L, Lenton EA, Anderton KJ, Brooke LM, Cooke ID (1978) The effects of Premarin and norgestrel on plasma FSH, LH and androstenedione in postmenopausal women. Postgrad Med J [Suppl 2] 54: 42–46
Siddle NC, Townsend PT, Young O, Minardi J, King RJB, Whitehead MI (1982) Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized postmenopausal endometrium. Acta Obstet Gynecol Scand [Suppl] 106: 17–22
Sipinen S (1979) Plasma estrone, estradiol and gonadotrophin concentrations in postmenopausal patients treated with estradiol or with a combination of estradiol and estriol. Research 11: 172–178
Strecker JR, Lauritzen C, Goessens L (1979) Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause. Maturitas 1: 183–190
Thom MH, White PJ, Williams RM, Sturdee DW, Peterson MEL, Wade-Evans T, Studd JWW (1979) Prevention and treatment of endometrial disease in climacteric women receiving estrogen therapy. Lancet 1: 455–457
Yen SSC, Martin PL, Burnier AM, Czekala NM, Greaney MO Jr, Callantine MR (1975) Circulating estradiol, estrone and gonadotrophin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol 40: 518–521
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mattsson, L.Å., Abrahamsson, L., Cullberg, G. et al. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins. Arch. Gynecol. 233, 101–107 (1983). https://doi.org/10.1007/BF02114786
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02114786